1. Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy. Issue 1 (2nd January 2019) Authors: Shima, Yoshihito; Kawaguchi, Yasushi; Kuwana, Masataka Journal: Modern rheumatology Issue: Volume 29:Issue 1(2019) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis. (8th February 2019) Authors: Morita, Takayoshi; Shima, Yoshihito; Fujimoto, Kosuke; Tsuboi, Hideki; Saeki, Yukihiko; Narazaki, Masashi; Ogata, Atsushi; Kumanogoh, Atsushi Journal: International immunology Issue: Volume 31:Number 5(2019) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus. Issue 10 (26th June 2018) Authors: Kato, Yasuhiro; Park, JeongHoon; Takamatsu, Hyota; Konaka, Hachirou; Aoki, Wataru; Aburaya, Syunsuke; Ueda, Mitsuyoshi; Nishide, Masayuki; Koyama, Shohei; Hayama, Yoshitomo; Kinehara, Yuhei; Hirano, Toru; Shima, Yoshihito; Narazaki, Masashi; Kumanogoh, Atsushi Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 10(2018) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma. Issue 2 (24th January 2023) Authors: Yoshioka, Fumie; Kato, Taigo; Shima, Yoshihito; Hatano, Koji; Kawashima, Atsunari; Fukuhara, Shinichiro; Imamura, Ryoichi; Nonomura, Norio Journal: IJU case reports Issue: Volume 6:Issue 2(2023) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab. Issue 1 (January 2015) Authors: Shima, Yoshihito; Hosen, Naoki; Hirano, Toru; Arimitsu, Junsuke; Nishida, Sumiyuki; Hagihara, Keisuke; Narazaki, Masashi; Ogata, Atsushi; Tanaka, Toshio; Kishimoto, Tadamitsu; Kumanogoh, Atsushi Journal: Modern rheumatology Issue: Volume 25:Issue 1(2015) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. Issue 6 (26th October 2010) Authors: Ogata, Atsushi; Morishima, Atsuyoshi; Hirano, Toru; Hishitani, Yoshihiro; Hagihara, Keisuke; Shima, Yoshihito; Narazaki, Masashi; Tanaka, Toshio Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 6(2011) Page Start: 1164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Minimal neonatal transfer of certolizumab pegol in a Japanese patient with rheumatoid arthritis. Issue 9 (22nd September 2017) Authors: Morita, Takayoshi; Fujimoto, Kosuke; Shima, Yoshihito; Ogata, Atsushi; Kumanogoh, Atsushi Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 9(2018) Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review. (2nd July 2020) Authors: Yamaguchi, Yuta; Maeda, Yuichi; Shibahara, Takayuki; Nameki, Shinichiro; Nakabayashi, Akihiko; Komuta, Kiyohide; Mizuno, Yumiko; Yagita, Mayu; Manabe, Yusuke; Morita, Takayoshi; Nishide, Masayuki; Watanabe, Akane; Takamatsu, Hyota; Nishida, Sumiyuki; Hirano, Toru; Shima, Yoshihito; Narazaki, Masa... Journal: Modern rheumatology case reports Issue: Volume 4:Number 2(2020) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications. Issue 6 (June 2015) Authors: Yoshida, Yuji; Ogata, Atsushi; Kang, Sujin; Ebina, Kousuke; Shi, Kenrin; Nojima, Satoshi; Kimura, Tetsuya; Ito, Daisuke; Morimoto, Keiko; Nishide, Masayuki; Hosokawa, Takashi; Hirano, Toru; Shima, Yoshihito; Narazaki, Masashi; Tsuboi, Hideki; Saeki, Yukihiko; Tomita, Tetsuya; Tanaka, Toshio; Kuma... Journal: Arthritis & rheumatology Issue: Volume 67:Issue 6(2015) Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. Issue 8 (17th April 2017) Authors: Nishide, Masayuki; Nojima, Satoshi; Ito, Daisuke; Takamatsu, Hyota; Koyama, Shohei; Kang, Sujin; Kimura, Tetsuya; Morimoto, Keiko; Hosokawa, Takashi; Hayama, Yoshitomo; Kinehara, Yuhei; Kato, Yasuhiro; Nakatani, Takeshi; Nakanishi, Yoshimitsu; Tsuda, Takeshi; Park, Jeong Hoon; Hirano, Toru; Shima... Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 8(2017) Page Start: 1440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗